Finance

Lists
EQ:NASDAQ
Equillium Inc
$2.28
-1.72%
(-0.040) 1D
$2.28
0.00% (0.00)
After hours
Closed: Jul 29, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EQ...
Open
$2.30
High
$2.36
Low
$2.18
Mkt. cap
144.16M
Avg. vol.
818.52K
Volume
2.00
52-wk high
$3.54
52-wk low
$0.37
EPS
-$0.32
Beta
1.77
Shares outstanding
63.23M
No. of employees
15
Open
$2.30
High
$2.36
Low
$2.18
Mkt. cap
144.16M
Avg. vol.
818.52K
Volume
2.00
52-wk high
$3.54
52-wk low
$0.37
EPS
-$0.32
Beta
1.77
Shares outstanding
63.23M
No. of employees
15
News stories
From sources across the web
About Equillium Inc
CEO-
Employees15
Founded2017
Headquarters-
SectorBiotechnology
Websiteequilliumbio.com
Analyst ratings
Based on 8 analysts giving stock ratings to EQ in the past 3 months
Strong buy
Buy
8
Hold
0
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for EQ in the last 3 months.
Highest
Current $2.28
$20.00 (+777.19%)
Average
$9.00 (+294.74%)
Lowest
$5.00 (+119.30%)
Analyst
Recommendation
Action
Price target
Projected
Date
Adam Walsh
Roth MKM
Buy
Reiterated
$12.00
+426.3%
07/24/2026
Kaveri Pohlman
Clear Street
Buy
Initiated
$9.00
+294.7%
07/22/2026
Yasmeen Rahimi
Piper Sandler
Buy
Initiated
$20.00
+777.2%
07/13/2026
Leland Gershell
Oppenheimer
Buy
Reiterated
$7.00
+207%
06/30/2026
William Wood
B. Riley Securities
Buy
Reiterated
$6.00
+163.2%
06/02/2026
Martin Auster
Raymond James
Buy
Maintained
$7.00
+207%
05/28/2026
Alex Thompson CFA
Stifel Nicolaus
Buy
Reiterated
$5.00
+119.3%
05/28/2026
Thomas Smith
Leerink Partners
Buy
Upgraded
$6.00
+163.2%
05/28/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Initiated
$10.00
+338.6%
04/07/2026
David Siffringer
Cantor Fitzgerald
Buy
Initiated
$10.00
+338.6%
04/07/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4.08M
1.30M
1.54M
2.99M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.14M
3.27M
2.43M
2.62M
Operating expense
6.23M
4.58M
3.96M
5.61M
Total operating expenses
6.23M
4.58M
3.96M
5.61M
Operating income
-6.23M
-4.58M
-3.96M
-5.61M
Other non operating income
-
-
-
-
EBT including unusual items
-5.74M
-4.23M
-3.78M
-5.31M
EBT excluding unusual items
-5.74M
-4.23M
-3.78M
-5.31M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5.74M
-4.23M
-3.78M
-5.31M
Net profit margin
-
-
-
-
Earnings per share
-0.16
-0.06
-0.04
-0.06
Interest and investment income
122.00K
235.00K
303.00K
309.00K
Interest expense
-
-
-
-
Net interest expenses
122.00K
235.00K
303.00K
309.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-6.20M
-4.55M
-3.94M
-5.59M
Gain or loss from assets sale
-
-
19.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer